COMPANY

inSoma Bio, Inc.

HQ: Durham, NC source · insomabio.com ↗ · Southeast

Also known as InSoma Bio · 8 sources

Location: Durham, NC · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Soft Tissue Soft Tissue Defects Subcutaneous Injection Implantation (injection) of a new biomatrix for soft tissue support.

1Trials (company is sponsor)7NIH grants

Timeline

Aug 11, 2025 Trial start Not phased (device or behavioral study): First-in-Human Safety Study for Fractomer™ Biomatrix source ↗

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07151638	First-in-Human Safety Study for Fractomer™ Biomatrix	Not phased (device or behavioral study)	Suspended	Aug 11, 2025	Dec 22, 2026 (estimated)

NIH awards 7

Annual award amounts. Total $3.4M.

Aug 16, 2024 NIH award 1R43GM153037-01A1 FY2024: $293,983 awarded for that fiscal year; activity R43 (SBIR); PI ROBERTS, STEFAN; recipient as written: INSOMA BIO, INC., DURHAM, NC. An off the shelf alternative to fat transfer for source ↗
Aug 1, 2024 NIH award 1R41NS135845-01A1 FY2024: $296,151 awarded for that fiscal year; activity R41 (STTR); PI ROBERTS, STEFAN; recipient as written: INSOMA BIO, INC., DURHAM, NC. Enhancing Peripheral Nerve Repair with an Inject source ↗
May 22, 2023 NIH award 5R44CA244110-03 FY2023: $1,035,879 awarded for that fiscal year; activity R44 (SBIR); PI ROBERTS, STEFAN; recipient as written: INSOMA BIO, INC., DURHAM, NC. A recombinant matrix to improve autologous tissu source ↗
Mar 31, 2023 NIH award 1R43GM149096-01A1 FY2023: $282,373 awarded for that fiscal year; activity R43 (SBIR); PI ROBERTS, STEFAN; recipient as written: INSOMA BIO, INC., DURHAM, NC. A recombinant elastin skin substitute for the t source ↗
Jun 24, 2022 NIH award 2R44CA244110-02A1 FY2022: $936,817 awarded for that fiscal year; activity R44 (SBIR); PI ROBERTS, STEFAN; recipient as written: INSOMA BIO, INC., DURHAM, NC. A recombinant matrix to improve autologous tissu source ↗
Sep 20, 2021 NIH award 1R43DK129121-01 FY2021: $290,768 awarded for that fiscal year; activity R43 (SBIR); PI ROBERTS, STEFAN; recipient as written: INSOMA BIO, INC., DURHAM, NC. Fully defined matrices for organoid culture source ↗
Sep 11, 2019 NIH award 1R41CA244110-01A1 FY2019: $254,627 awarded for that fiscal year; activity R41 (STTR); PI ROBERTS, STEFAN; recipient as written: INSOMA BIO, INC., DURHAM, NC. A recombinant matrix to improve autologous tissu source ↗